Nanobac Pharmaceuticals Stock Forecast - Naive Prediction

NNBP Stock  USD 0.0001  0.00  0.00%   
The Naive Prediction forecasted value of Nanobac Pharmaceuticals Incorporated on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Nanobac Stock Forecast is based on your current time horizon. Although Nanobac Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Nanobac Pharmaceuticals' systematic risk associated with finding meaningful patterns of Nanobac Pharmaceuticals fundamentals over time.
  
As of 01/22/2025, Inventory Turnover is likely to drop to 1.54. In addition to that, Payables Turnover is likely to drop to 0.01. As of 01/22/2025, Net Loss is likely to drop to about (7.9 M).

Nanobac Pharmaceuticals Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Nanobac Pharmaceuticals' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
2010-12-31
Previous Quarter
3.5 K
Current Value
3.4 K
Quarterly Volatility
11.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Nanobac Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Nanobac Pharmaceuticals Incorporated value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Nanobac Pharmaceuticals Naive Prediction Price Forecast For the 23rd of January

Given 90 days horizon, the Naive Prediction forecasted value of Nanobac Pharmaceuticals Incorporated on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Nanobac Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nanobac Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Nanobac Pharmaceuticals Stock Forecast Pattern

Backtest Nanobac PharmaceuticalsNanobac Pharmaceuticals Price PredictionBuy or Sell Advice 

Nanobac Pharmaceuticals Forecasted Value

In the context of forecasting Nanobac Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nanobac Pharmaceuticals' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Nanobac Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0001
0.0001
Downside
0.0001
Expected Value
0.0001
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Nanobac Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Nanobac Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria30.385
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
This model is not at all useful as a medium-long range forecasting tool of Nanobac Pharmaceuticals Incorporated. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Nanobac Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Nanobac Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nanobac Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nanobac Pharmaceuticals. Your research has to be compared to or analyzed against Nanobac Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Nanobac Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nanobac Pharmaceuticals.

Other Forecasting Options for Nanobac Pharmaceuticals

For every potential investor in Nanobac, whether a beginner or expert, Nanobac Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nanobac Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nanobac. Basic forecasting techniques help filter out the noise by identifying Nanobac Pharmaceuticals' price trends.

View Nanobac Pharmaceuticals Related Equities

 Risk & Return  Correlation

Nanobac Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nanobac Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nanobac Pharmaceuticals' current price.

Nanobac Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Nanobac Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nanobac Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Nanobac Pharmaceuticals stock market strength indicators, traders can identify Nanobac Pharmaceuticals Incorporated entry and exit signals to maximize returns.

Additional Tools for Nanobac Stock Analysis

When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.